Recursion Pharmaceuticals (RXRX) Exchange Rate Effect (2022 - 2025)
Historic Exchange Rate Effect for Recursion Pharmaceuticals (RXRX) over the last 4 years, with Q3 2025 value amounting to $1.9 million.
- Recursion Pharmaceuticals' Exchange Rate Effect rose 36377.17% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year increase of 647105.26%. This contributed to the annual value of -$3.4 million for FY2024, which is 191170.21% down from last year.
- Recursion Pharmaceuticals' Exchange Rate Effect amounted to $1.9 million in Q3 2025, which was up 36377.17% from $9.3 million recorded in Q2 2025.
- In the past 5 years, Recursion Pharmaceuticals' Exchange Rate Effect ranged from a high of $9.3 million in Q2 2025 and a low of -$3.5 million during Q4 2024
- Over the past 4 years, Recursion Pharmaceuticals' median Exchange Rate Effect value was $61000.0 (recorded in 2023), while the average stood at $1.0 million.
- As far as peak fluctuations go, Recursion Pharmaceuticals' Exchange Rate Effect crashed by 1085000.0% in 2024, and later surged by 794322.03% in 2025.
- Over the past 4 years, Recursion Pharmaceuticals' Exchange Rate Effect (Quarter) stood at -$307000.0 in 2022, then soared by 140.39% to $124000.0 in 2023, then plummeted by 2900.0% to -$3.5 million in 2024, then skyrocketed by 153.83% to $1.9 million in 2025.
- Its last three reported values are $1.9 million in Q3 2025, $9.3 million for Q2 2025, and $4.8 million during Q1 2025.